Par Drugs And Chemicals Limited has informed the Exchange about Action(s) initiated or orders passed
PAR · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Par Drugs and Chemicals informed the exchange that its Promoter and Independent Director met with SEBI's Corporation Finance Investigation Department officials on June 18, 2025 in Mumbai. The meeting was in connection with the company's earlier February 14, 2025 announcement about a slump sale of its existing establishment (land, building, plant & machinery, and specific current assets/liabilities) to Phal-Jig Fine Chemicals Private Limited. The management made representations before SEBI, and the regulator indicated that a formal communication seeking further information and clarifications will be issued via email. The company stated that no violation or contravention has been alleged and there is no financial or operational impact on the listed entity at this stage.
The development signals regulatory scrutiny of the slump sale transaction but is not yet adverse. Investors should watch for the formal SEBI communication, which could bring clarity on whether further action is warranted. Short-term sentiment may be cautious given the ongoing inquiry.